Belvedere Research
For CompaniesAboutRequest Coverage

Data page

Micro-Cap Healthcare Companies

A structured screen of healthcare issuers in the Belvedere universe using SEC revenue as a disclosure-size proxy. This is not a list of stocks to buy and not a market-cap index.

Belvedere does not currently display licensed market capitalization. The screens below use latest reported quarterly revenue from SEC XBRL as a disclosure-size proxy, not as a market-cap category. On this page, “micro-cap” means latest reported quarterly revenue below $50 million among Healthcare and Biotechnology issuers. It is not a NYSE/Nasdaq or Russell market-cap band.

Data dateSep 21, 2026
SourceSEC EDGAR XBRL
Market capNot used
Document typeData page

What is a micro-cap company on Belvedere?

Until licensed market-cap data is configured, Belvedere uses latest quarterly SEC revenue below $50 million as a disclosure-size proxy. That is not the SEC’s or an index provider’s market-cap definition.

Are these the top micro-cap healthcare stocks?

No. The table is the current eligible universe, not a ranked ‘best stocks’ list. Growth ranking is a separate, methodology-defined screen.

Universe table

Public companies in the Belvedere universe
CompanyTickerIndustryRevenueGrowthBelvedere FCFLatest filingResearch

Showing 0 of 0 healthcare issuers in the micro-cap revenue proxy.

Fastest-growing in this screen

No issuers in this filter currently have comparable YoY revenue growth.

Positive Belvedere FCF

0 issuers have positive Belvedere free cash flow (operating cash flow minus capex). That figure may differ from company-defined non-GAAP FCF.

Growing revenue

0 issuers currently show positive latest-quarter YoY revenue growth in the extract.

Companies with Belvedere research

No issuer in the current micro-cap healthcare proxy has an active Belvedere initiation in the archive.

Methodology

Universe, eligibility, and limitations

Eligibility

  • Company is in the Belvedere operating-company universe
  • Sector mapping is Healthcare or Biotechnology from SIC metadata
  • Latest quarterly revenue is greater than $0 and less than $50 million

Limitations

  • Revenue is not market capitalization
  • Industry sub-groups are keyword mappings from SIC descriptions and can be imperfect
  • Missing FCF or growth facts are shown as blanks rather than estimated
  • No buy, sell, or hold recommendations
Small-cap healthcare companiesMicro-cap equity researchHealthcare revenue-growth rankingHealthcare industry

Frequently asked questions

What is a micro-cap company on Belvedere?
Until licensed market-cap data is configured, Belvedere uses latest quarterly SEC revenue below $50 million as a disclosure-size proxy. That is not the SEC’s or an index provider’s market-cap definition.
Are these the top micro-cap healthcare stocks?
No. The table is the current eligible universe, not a ranked ‘best stocks’ list. Growth ranking is a separate, methodology-defined screen.
Does Belvedere model clinical pipelines here?
No. This data page is a SIC-mapped revenue proxy with sourced financials. Clinical assets appear only in a cited, human-reviewed note.

For public companies

Request research coverage

Compensation does not purchase ranking placement or research conclusions.

Request Coverage